The long-awaited FDA clearance sets up a showdown in the surgical robotics market between Medtronic and Intuitive Surgical.

Medtronic (NYSE: MDT) announced today that the FDA cleared its Hugo robotic-assisted surgery system for use in urologic surgical procedures.

The global surgical robotics market is forecast to grow at a compound annual growth rate (CAGR) of 15% between 2025 and 2030.

The nonprofit Second Helpings has welcomed three new members to its board of directors. Renata Johnson Green, John Shoulders, ...

Profound Medical Corp. announced that Dr. Pejman Ghanouni from Stanford University received the Cum Laude award at the RSNA Annual Meeting for his presentation on the CAPTAIN trial, which compares the ...

With the U.S. authorization for urologic procedures, “there is now choice” for hospitals that want to expand their robotic ...

Hugo is heading to the U.S., with Medtronic finally securing a stateside clearance for its robotic surgery platform. | The ...

The treatment is suitable for men whose cancer has not spread outside of the prostate gland or has spread to the area just ...

Global Biopsy Devices Market OverviewThe global biopsy devices market is expected to expand at a steady growth rate of 7% over the next five years, supported by rising cancer prevalence, increasing ...

Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies for ...